北京市鲁谷社区卫生服务中心应用抗骨质疏松药物的合理性分析

发布时间：2018-11-10 09:33

【摘要】：目的:促进北京市鲁谷社区合理应用抗骨质疏松药物。方法:以药物的销售金额、用药频度(DDDs)及日均费用(DDC)为指标对鲁谷社区卫生服务中心(以下简称我中心)2012年7月-2013年6月与2013年7月-2014年6月抗骨质疏松药物使用情况进行回顾性分析。结果:我中心抗骨质疏松药物销售金额逐年上涨,占药物总销售金额比例也有所增长。主要品种为钙制剂类、维生素D类、双膦酸盐类和中成药类,其中中成药的销售金额所占比例较大,2年间基本持平;碳酸钙D3片的销售金额所占比例和DDDs最高;骨化三醇胶丸、骨疏康胶囊和骨康胶囊的DDC较高。结论:中成药用于治疗骨质疏松症,因缺乏大型的临床研究证据,应慎重选择。目前,我中心抗骨质疏松药物用药品种较单一,与社区医院的抗骨质疏松药物品种有限以及社区医务人员对骨质疏松症相关知识知晓率低有关。应增强对骨质疏松症的重视,通过培训提高医务人员和患者对相关知识的知晓率。
[Abstract]:Objective: to promote the rational use of anti-osteoporosis drugs in Lugu community of Beijing. Methods: according to the sales amount of drugs, Drug frequency (DDDs) and daily average cost (DDC) were analyzed retrospectively in Lugu Community Health Service Center from July 2012 to June 2013 and from July 2013 to June 2014. Results: the amount of anti-osteoporosis drugs increased year by year, and the proportion of total drug sales increased. The main varieties are calcium preparations, vitamin D, bisphosphonates and proprietary Chinese medicines, which account for a large proportion of the sales amount of proprietary Chinese medicine, and the proportion of sales amount of calcium carbonate D3 tablets is the highest, and the proportion of DDDs is the highest in the past two years. The DDC of Gushukang capsule, Gushukang capsule and Gukang capsule was higher than that of calcitriol gel pill. Conclusion: for the treatment of osteoporosis, Chinese patent medicine should be carefully chosen because of the lack of large-scale clinical research evidence. At present, the variety of anti-osteoporosis drugs in our center is relatively single, which is related to the limited variety of anti-osteoporosis drugs in community hospitals and the low awareness rate of community medical staff about osteoporosis. We should pay more attention to osteoporosis and raise the awareness rate of medical staff and patients about relevant knowledge through training.
【作者单位】：首都医科大学附属北京朝阳医院西区药事办;
【分类号】：R969.3

【参考文献】